ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

GSK Gsk Plc

1,761.00
0.00 (0.00%)
08 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Gsk Plc LSE:GSK London Ordinary Share GB00BN7SWP63 ORD 31 1/4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 1,761.00 1,757.50 1,758.00 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 30.33B 4.93B 1.1970 14.69 72.38B
Gsk Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker GSK. The last closing price for Gsk was 1,761p. Over the last year, Gsk shares have traded in a share price range of 1,302.60p to 1,767.00p.

Gsk currently has 4,117,033,438 shares in issue. The market capitalisation of Gsk is £72.38 billion. Gsk has a price to earnings ratio (PE ratio) of 14.69.

Gsk Share Discussion Threads

Showing 19826 to 19846 of 33150 messages
Chat Pages: Latest  798  797  796  795  794  793  792  791  790  789  788  787  Older
DateSubjectAuthorDiscuss
24/7/2019
12:21
wow what was that????
lippy4
24/7/2019
12:14
I take it the results were good ;-)
zho
23/7/2019
08:07
GlaxoSmithKline PLC (GSK.LN) said Monday that has found positive data over a 96-week period from phase 3 study of investigational Fostemsavir in patients with HIV.
ViiV Healthcare, of which GlaxoSmithKline is a majority shareholder, said rates of virologic suppression and immunologic response increased from week 48 to week 96 in a difficult-to-treat population with multi-drug resistant HIV-1.
The study found that at week 96, 60% of patients receiving Fostemsavir as well as optimized background treatments in the randomized cohort achieved virologic suppression--an increase of 6% from week 48 results.
ViiV plans to begin the submission of regulatory applications for Fostemsavir with the U.S. new-drug application later this year.

tradermichael
22/7/2019
17:36
Sold today as well...
In sync with the number one trader it seems :)

crossing_the_rubicon
22/7/2019
15:53
Sold today at 1658p, hopefully get these again below 1600p make 58p per share.
montyhedge
17/7/2019
09:56
Very little movement this morning, waiting for direction …… ;o)
tradermichael
16/7/2019
16:06
I won't be swinging this summer (-; ...
sogoesit
16/7/2019
13:53
I just unloaded half my remaining GSK shares at 1671p. Still have the other half, so don't mind whether there's a swing or not.
thamestrader
16/7/2019
13:44
I unloaded £106k @ 1606p or thereabouts and am still awaiting the swing.....:-(spud
spud
16/7/2019
13:21
Well done.
alphorn
16/7/2019
13:04
1600p is the new 1500p and that's the start of the new trading range.

I unloaded a huge number of GSK shares today at 1666p, waiting for the swing …. ;0)

tradermichael
16/7/2019
12:47
£17-17.50 is big resistance let's not get too carried away ?
tim 3
16/7/2019
12:39
even faster than a porsche ....
lippy4
16/7/2019
12:28
Yes it would be nice to get back to the £20 days again. I used to trade this. buy around 1750 sell at £20 did it several times then i did a spread at 1750 and it dropped to £10 think i sold about £14 painful but always said if people asked me for a tip around that time buy GSK for a tenner and youll do well. They had a few opportunities to do this. these days its been start buying when it goes to £14 and start selling £15-1550 and get 6% while u wait. Now its broken out who knows
stpalm
16/7/2019
11:24
£1 = $1.24
tradermichael
15/7/2019
16:23
Upwards and onwards... 1700 next.
sogoesit
15/7/2019
14:59
My target is 1910p if break up.
montyhedge
15/7/2019
14:33
NOW TRADING AT A TWO YEAR HIGH

and showing distinct strength.


ALL IMO. DYOR.
QP

quepassa
14/7/2019
08:00
Hundreds of thousands of CJD cases have been misdiagnosed in the USA as Alzheimer's
--------------------------------------------------------------------------

The BBC2 programme , Mad Cow the new new wave las thursaday at 9pm, didn't dare pick up on this, because it was warned off.

But it means that 100% of surgical instruments should be tested for protein residue for EVERY type of operation not just neurology and eye surgery and a few others as detailed in DOH HTM 01-01 2016 update , here is why:

2003



'' Now people are beginning to realize that because something looks like sporadic CJD they can't necessarily conclude that it's not linked to (mad cow disease)," said Laura Manuelidis, section chief of surgery in the neuropathology department at Yale University, who conducted a 1989 study that found 13 percent of Alzheimer's patients actually had CJD.

Several studies, including the one by Manuelidis, have found autopsies reveal 3-percent-to-13-percent of patients diagnosed with Alzheimer's or dementia actually suffered from CJD. Those numbers might sound low, but there are 4-million Alzheimer's cases and hundreds of thousands of dementia cases in the United States. A small percentage of those cases could add up to 120,000 or more CJD victims going undetected and not included in official statistics.''





buywell notes

In 2003

From the Laura Manuelidis, section chief of surgery in the neuropathology department at Yale University findings in 2003:

At her lower end figure of 3% of misdiagnosed Alzheimer's cases which should have been diagnosed as CJD, this works out that there should be a minimum of 120,000 cases a year minimum of CJD being diagnosed.

In 2018

5.7 million Americans of all ages are now diagnosed as having Alzheimer’s and now someone in the United States is being diagnosed with Alzheimer’s disease every 65 seconds.


Based upon the average range of the studies which misdiagnosed Alzheimer's which should have been diagnosed as CJD ie 3% to 13% , average = 8%


The number of people in the USA today that should be diagnosed with a form of CJD is 8% of 5.7M = 456,000.

Yes 456,000 of CJD cases in the USA that have at present been wrongly diagnosed as Alzheimer's



WHY is this happening and why are CJD cases not been diagnosed correctly ?
-----------------------------------------------------------------


buywell thinks this is because:

1. No piece of test equipment exists that can test for any form of CJD ( at least
eight types now exist, more being identified) in a living human being.

2. CJD can at present only be 100% correctly identified by post-mortem


3. CJD is a prion disease always fatal and no cure ... like Alzheimer's. Hospital
staff know this and also that it is highly contagious and transmissible
disease, they are scared of catching it themselves and rightly so.



There is a development in the USA where some state universities are trying to develop a piece of test equipment that will detect CWD in a living deer. ( CWD is a TSE, like BSE, a prion disease in Cervids)

One has to ask why is the FDA and USA government not involved or at least funding this ?

buywell thinks because such a piece if new test equipment can then be modified to detect CJD in humans and then case numbers will rocket to the hundreds of thousands causing mass panic.

buywell3
11/7/2019
13:31
Well, taking those in tablet form beats eating dog or snake as a meal in China and Korea, I suppose!
sogoesit
11/7/2019
09:21
Yes, dividend into my Selftrade account this morning :-)
philanderer
Chat Pages: Latest  798  797  796  795  794  793  792  791  790  789  788  787  Older

Your Recent History

Delayed Upgrade Clock